Raycure Drugs Limited - chemicals in Chandigarh, India. FY 2026 financials & compliance.
CIN U00304CH2006PLC029458 Incorporated 02 January 2006 ROC Chandigarh HQ Chandigarh, India
Active Public Limited Company chemicals
Revenue · FY 2017
₹45.18 Lakh
▼ 17% YoY
Net loss · FY 2017
₹25,129
Net margin -0.6%
EBITDA · FY 2017
-₹22,362
EBITDA margin -0.5%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
20 yrs
Est. 2006
Directors on board
3
As per MCA filings
GST registrations
1
None active

About Raycure Drugs Limited

Data last updated:

Raycure Drugs Limited is a public limited company based in Chandigarh, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 02 January 2006 and has been in existence for over 20 years.

The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U00304CH2006PLC029458. The company has 1 GST registration on record, which is no longer active.

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Tarsem Kumar Ruby and Veeta Sharma.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO 859 Nac Manimajra U.T. Chandigarh., Chandigarh, India.

As per the financials filed for FY 2017, the company reported a revenue of ₹45.18 Lakh, a decline of 17% compared to the previous year. For the same year it recorded a net loss of ₹25,129 (net margin -0.6%) and EBITDA of -₹22,362 (EBITDA margin -0.5%).

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U00304CH2006PLC029458
Registration Number 029458
Incorporation Date 02 January 2006
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Raycure Drugs Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    SCO 859 Nac Manimajra U.T. Chandigarh., Chandigarh, India
  • Industry
    Chemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals

To see the full contact details of Raycure Drugs Limited, buy the company report.

Comprehensive company report
Raycure Drugs Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Raycure Drugs Limited

FY 2025 filings available

Raycure Drugs Limited reported revenue of ₹45.18 Lakh (down 17% YoY) for FY 2017.

Revenue · FY 2017
₹45.18 Lakh ▼ 17%
Net loss · FY 2017
₹25,129 margin -0.6%
EBITDA · FY 2017
-₹22,362 margin -0.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 17%

Revenue fell 17% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations₹45.18 Lakh
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹22,362
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹25,129
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin-0.5%
Net Profit Margin-0.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Raycure Drugs Limited, buy the company report.

Board of directors of Raycure Drugs Limited

Raycure Drugs has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Tarsem Kumar RubyDirector02 Jan 200620 Years 10 MonthsCurrent
Veeta SharmaDirector02 Jan 200620 Years 10 MonthsCurrent
Sanjay JhambAdditional Director31 Aug 20206 Years 2 MonthsCurrent

Auditor

Raycure Drugs Limited is audited by ATUL CHOPRA & CO. for the financial year 2017.

Auditor firmFinancial yearFirm registration number
ATUL CHOPRA & CO.FY 2017012289N

Shareholding

The shareholding of Raycure Drugs Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Raycure Drugs Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Raycure Drugs Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Raycure Drugs has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Raycure Drugs Limited, buy the company report.

Recent activity

Raycure Drugs Limited has 4 board changes on record since 2006: 3 appointments and 1 cessation. The latest: Sanjay Jhamb was appointed as Additional Director on 31 Aug 2020.

AGM
Raycure Drugs Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Raycure Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Appointed
Sanjay Jhamb was appointed as Additional Director.
Ceased
Sat Parkash Mittal ceased to be Director.
Appointed
Tarsem Kumar Ruby was appointed as Director.
Appointed
Veeta Sharma was appointed as Director.
Incorporation
02 Jan 2006
Raycure Drugs Limited was registered on 02 Jan 2006 with Roc Chandigarh & aged 20 years 10 months as per MCA records.

Frequently asked questions

Raycure Drugs is an active public limited company based in Chandigarh, India. The company works in chemical products, within the chemicals industry. It was incorporated on 02 January 2006 (20+ years old) and is registered under CIN U00304CH2006PLC029458.

Raycure Drugs has 3 current directors:

The latest financial statements of Raycure Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

No. Raycure Drugs has 1 GST registration on record and it is cancelled or inactive.

The CIN (Corporate Identification Number) of Raycure Drugs is U00304CH2006PLC029458. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Raycure Drugs was incorporated on 02 January 2006, making it 20+ years old. It is registered with the Registrar of Companies, Chandigarh.

Sanjay Jhamb was appointed as Additional Director on 31 Aug 2020. Sat Parkash Mittal ceased to be Director on 31 Aug 2020. Tarsem Kumar Ruby was appointed as Director on 02 Jan 2006. Raycure Drugs has 4 board changes on record in total.

The registered office of Raycure Drugs is at SCO 859 Nac Manimajra U.T. Chandigarh., Chandigarh, India.

Raycure Drugs operates in the chemicals industry, in the chemical products segment.

The compliance status of Raycure Drugs is compliant as of 06 July 2026. The company is actively filing with the Registrar of Companies.